Sign In
Get Started →
Summarize Shruti Agarwal’s background before I meet with them
Profile Image for Shruti Agarwal

Shruti Agarwal

Founder, NeedleSpotter - Bridging the gap between scientific and commercial expertise - Marketing Strategy Leader for Biotech and Pharmaceutical companies - Oncology - High Science - ISB - NII
Clay User Badge
New York City Metropolitan Area
SummaryAI Assisted Badge

Shruti Agarwal is a pharmaceutical strategy leader with a strong track record in commercializing brands and maximizing brand performance in competitive markets, particularly in the Oncology sector with expertise in small molecule, antibody, and cell therapies.

She has been recognized for her leadership in driving product revenue growth, spearheading brand success, and implementing innovative marketing strategies in the pharmaceutical industry.

With a unique background combining medical and commercial expertise, Shruti holds a PhD in cell biology, an MBA in marketing and strategy, and experience in areas such as medical affairs, analytics, and marketing.

Her educational journey includes studies at Indian School of Business, NII - National Institute of Immunology, National Institute of Pharmaceutical Education and Research, and Hemwati Nandan Bahuguna Garhwal University.

Shruti's professional experience spans across various roles at Novartis, where she has led teams and initiatives in product strategy, marketing, business analytics, professional promotions, digital strategy, and business planning within the Hematology and CART Therapies divisions.

She also founded NeedleSpotter Inc. and has engaged in niche strategy consulting, demonstrating her ability to establish and lead successful ventures.

Shruti's accomplishments include driving product revenue growth from $250M to over $1B, winning the Novartis Hematology Marketer of the Year Award, and leading innovative marketing implementations in oncology.

Her expertise in cross-functional team leadership, collaborative partnerships, and strategic thinking has been instrumental in achieving business objectives and delivering exceptional results in the pharmaceutical industry.

This public profile is provided courtesy of Clay. All information found here is in the public domain.